Global Meningococcal Conjugate Market Research Report 2022

Global Meningococcal Conjugate Market Research Report 2022

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Meningococcal Conjugate Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Menactra
1.2.3 Menveo
1.2.4 NeisVac-C
1.2.5 Nimenrix
1.2.6 Others
1.3 Market by End User
1.3.1 Global Meningococcal Conjugate Market Share by End User: 2017 VS 2021 VS 2028
1.3.2 Children
1.3.3 Preteens or Teens
1.3.4 Adults
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Meningococcal Conjugate Market Perspective (2017-2028)
2.2 Meningococcal Conjugate Growth Trends by Region
2.2.1 Meningococcal Conjugate Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Meningococcal Conjugate Historic Market Size by Region (2017-2022)
2.2.3 Meningococcal Conjugate Forecasted Market Size by Region (2023-2028)
2.3 Meningococcal Conjugate Market Dynamics
2.3.1 Meningococcal Conjugate Industry Trends
2.3.2 Meningococcal Conjugate Market Drivers
2.3.3 Meningococcal Conjugate Market Challenges
2.3.4 Meningococcal Conjugate Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Meningococcal Conjugate Players by Revenue
3.1.1 Global Top Meningococcal Conjugate Players by Revenue (2017-2022)
3.1.2 Global Meningococcal Conjugate Revenue Market Share by Players (2017-2022)
3.2 Global Meningococcal Conjugate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Meningococcal Conjugate Revenue
3.4 Global Meningococcal Conjugate Market Concentration Ratio
3.4.1 Global Meningococcal Conjugate Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Meningococcal Conjugate Revenue in 2021
3.5 Meningococcal Conjugate Key Players Head office and Area Served
3.6 Key Players Meningococcal Conjugate Product Solution and Service
3.7 Date of Enter into Meningococcal Conjugate Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Meningococcal Conjugate Breakdown Data by Type
4.1 Global Meningococcal Conjugate Historic Market Size by Type (2017-2022)
4.2 Global Meningococcal Conjugate Forecasted Market Size by Type (2023-2028)
5 Meningococcal Conjugate Breakdown Data by End User
5.1 Global Meningococcal Conjugate Historic Market Size by End User (2017-2022)
5.2 Global Meningococcal Conjugate Forecasted Market Size by End User (2023-2028)
6 North America
6.1 North America Meningococcal Conjugate Market Size (2017-2028)
6.2 North America Meningococcal Conjugate Market Size by Country (2017-2022)
6.3 North America Meningococcal Conjugate Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Meningococcal Conjugate Market Size (2017-2028)
7.2 Europe Meningococcal Conjugate Market Size by Country (2017-2022)
7.3 Europe Meningococcal Conjugate Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Meningococcal Conjugate Market Size (2017-2028)
8.2 Asia-Pacific Meningococcal Conjugate Market Size by Country (2017-2022)
8.3 Asia-Pacific Meningococcal Conjugate Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Meningococcal Conjugate Market Size (2017-2028)
9.2 Latin America Meningococcal Conjugate Market Size by Country (2017-2022)
9.3 Latin America Meningococcal Conjugate Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Meningococcal Conjugate Market Size (2017-2028)
10.2 Middle East & Africa Meningococcal Conjugate Market Size by Country (2017-2022)
10.3 Middle East & Africa Meningococcal Conjugate Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Sanofi Pasteur
11.1.1 Sanofi Pasteur Company Detail
11.1.2 Sanofi Pasteur Business Overview
11.1.3 Sanofi Pasteur Meningococcal Conjugate Introduction
11.1.4 Sanofi Pasteur Revenue in Meningococcal Conjugate Business (2017-2022)
11.1.5 Sanofi Pasteur Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Meningococcal Conjugate Introduction
11.2.4 Pfizer Revenue in Meningococcal Conjugate Business (2017-2022)
11.2.5 Pfizer Recent Development
11.3 Glaxo Smith Kline
11.3.1 Glaxo Smith Kline Company Detail
11.3.2 Glaxo Smith Kline Business Overview
11.3.3 Glaxo Smith Kline Meningococcal Conjugate Introduction
11.3.4 Glaxo Smith Kline Revenue in Meningococcal Conjugate Business (2017-2022)
11.3.5 Glaxo Smith Kline Recent Development
11.4 Hualan Biological Engineering
11.4.1 Hualan Biological Engineering Company Detail
11.4.2 Hualan Biological Engineering Business Overview
11.4.3 Hualan Biological Engineering Meningococcal Conjugate Introduction
11.4.4 Hualan Biological Engineering Revenue in Meningococcal Conjugate Business (2017-2022)
11.4.5 Hualan Biological Engineering Recent Development
11.5 JN International Medical Corporation
11.5.1 JN International Medical Corporation Company Detail
11.5.2 JN International Medical Corporation Business Overview
11.5.3 JN International Medical Corporation Meningococcal Conjugate Introduction
11.5.4 JN International Medical Corporation Revenue in Meningococcal Conjugate Business (2017-2022)
11.5.5 JN International Medical Corporation Recent Development
11.6 Baxter International
11.6.1 Baxter International Company Detail
11.6.2 Baxter International Business Overview
11.6.3 Baxter International Meningococcal Conjugate Introduction
11.6.4 Baxter International Revenue in Meningococcal Conjugate Business (2017-2022)
11.6.5 Baxter International Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Meningococcal Conjugate Introduction
11.7.4 Merck Revenue in Meningococcal Conjugate Business (2017-2022)
11.7.5 Merck Recent Development
11.8 Serum Institute of India
11.8.1 Serum Institute of India Company Detail
11.8.2 Serum Institute of India Business Overview
11.8.3 Serum Institute of India Meningococcal Conjugate Introduction
11.8.4 Serum Institute of India Revenue in Meningococcal Conjugate Business (2017-2022)
11.8.5 Serum Institute of India Recent Development
11.9 Biomed
11.9.1 Biomed Company Detail
11.9.2 Biomed Business Overview
11.9.3 Biomed Meningococcal Conjugate Introduction
11.9.4 Biomed Revenue in Meningococcal Conjugate Business (2017-2022)
11.9.5 Biomed Recent Development
11.10 Novartis
11.10.1 Novartis Company Detail
11.10.2 Novartis Business Overview
11.10.3 Novartis Meningococcal Conjugate Introduction
11.10.4 Novartis Revenue in Meningococcal Conjugate Business (2017-2022)
11.10.5 Novartis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Meningococcal Conjugate Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Menactra
Table 3. Key Players of Menveo
Table 4. Key Players of NeisVac-C
Table 5. Key Players of Nimenrix
Table 6. Key Players of Others
Table 7. Global Meningococcal Conjugate Market Size Growth by End User (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Meningococcal Conjugate Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Meningococcal Conjugate Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Meningococcal Conjugate Market Share by Region (2017-2022)
Table 11. Global Meningococcal Conjugate Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Meningococcal Conjugate Market Share by Region (2023-2028)
Table 13. Meningococcal Conjugate Market Trends
Table 14. Meningococcal Conjugate Market Drivers
Table 15. Meningococcal Conjugate Market Challenges
Table 16. Meningococcal Conjugate Market Restraints
Table 17. Global Meningococcal Conjugate Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Meningococcal Conjugate Market Share by Players (2017-2022)
Table 19. Global Top Meningococcal Conjugate Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Conjugate as of 2021)
Table 20. Ranking of Global Top Meningococcal Conjugate Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Meningococcal Conjugate Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Meningococcal Conjugate Product Solution and Service
Table 24. Date of Enter into Meningococcal Conjugate Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Meningococcal Conjugate Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Meningococcal Conjugate Revenue Market Share by Type (2017-2022)
Table 28. Global Meningococcal Conjugate Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Meningococcal Conjugate Revenue Market Share by Type (2023-2028)
Table 30. Global Meningococcal Conjugate Market Size by End User (2017-2022) & (US$ Million)
Table 31. Global Meningococcal Conjugate Revenue Market Share by End User (2017-2022)
Table 32. Global Meningococcal Conjugate Forecasted Market Size by End User (2023-2028) & (US$ Million)
Table 33. Global Meningococcal Conjugate Revenue Market Share by End User (2023-2028)
Table 34. North America Meningococcal Conjugate Market Size by Country (2017-2022) & (US$ Million)
Table 35. North America Meningococcal Conjugate Market Size by Country (2023-2028) & (US$ Million)
Table 36. Europe Meningococcal Conjugate Market Size by Country (2017-2022) & (US$ Million)
Table 37. Europe Meningococcal Conjugate Market Size by Country (2023-2028) & (US$ Million)
Table 38. Asia-Pacific Meningococcal Conjugate Market Size by Region (2017-2022) & (US$ Million)
Table 39. Asia-Pacific Meningococcal Conjugate Market Size by Region (2023-2028) & (US$ Million)
Table 40. Latin America Meningococcal Conjugate Market Size by Country (2017-2022) & (US$ Million)
Table 41. Latin America Meningococcal Conjugate Market Size by Country (2023-2028) & (US$ Million)
Table 42. Middle East & Africa Meningococcal Conjugate Market Size by Country (2017-2022) & (US$ Million)
Table 43. Middle East & Africa Meningococcal Conjugate Market Size by Country (2023-2028) & (US$ Million)
Table 44. Sanofi Pasteur Company Detail
Table 45. Sanofi Pasteur Business Overview
Table 46. Sanofi Pasteur Meningococcal Conjugate Product
Table 47. Sanofi Pasteur Revenue in Meningococcal Conjugate Business (2017-2022) & (US$ Million)
Table 48. Sanofi Pasteur Recent Development
Table 49. Pfizer Company Detail
Table 50. Pfizer Business Overview
Table 51. Pfizer Meningococcal Conjugate Product
Table 52. Pfizer Revenue in Meningococcal Conjugate Business (2017-2022) & (US$ Million)
Table 53. Pfizer Recent Development
Table 54. Glaxo Smith Kline Company Detail
Table 55. Glaxo Smith Kline Business Overview
Table 56. Glaxo Smith Kline Meningococcal Conjugate Product
Table 57. Glaxo Smith Kline Revenue in Meningococcal Conjugate Business (2017-2022) & (US$ Million)
Table 58. Glaxo Smith Kline Recent Development
Table 59. Hualan Biological Engineering Company Detail
Table 60. Hualan Biological Engineering Business Overview
Table 61. Hualan Biological Engineering Meningococcal Conjugate Product
Table 62. Hualan Biological Engineering Revenue in Meningococcal Conjugate Business (2017-2022) & (US$ Million)
Table 63. Hualan Biological Engineering Recent Development
Table 64. JN International Medical Corporation Company Detail
Table 65. JN International Medical Corporation Business Overview
Table 66. JN International Medical Corporation Meningococcal Conjugate Product
Table 67. JN International Medical Corporation Revenue in Meningococcal Conjugate Business (2017-2022) & (US$ Million)
Table 68. JN International Medical Corporation Recent Development
Table 69. Baxter International Company Detail
Table 70. Baxter International Business Overview
Table 71. Baxter International Meningococcal Conjugate Product
Table 72. Baxter International Revenue in Meningococcal Conjugate Business (2017-2022) & (US$ Million)
Table 73. Baxter International Recent Development
Table 74. Merck Company Detail
Table 75. Merck Business Overview
Table 76. Merck Meningococcal Conjugate Product
Table 77. Merck Revenue in Meningococcal Conjugate Business (2017-2022) & (US$ Million)
Table 78. Merck Recent Development
Table 79. Serum Institute of India Company Detail
Table 80. Serum Institute of India Business Overview
Table 81. Serum Institute of India Meningococcal Conjugate Product
Table 82. Serum Institute of India Revenue in Meningococcal Conjugate Business (2017-2022) & (US$ Million)
Table 83. Serum Institute of India Recent Development
Table 84. Biomed Company Detail
Table 85. Biomed Business Overview
Table 86. Biomed Meningococcal Conjugate Product
Table 87. Biomed Revenue in Meningococcal Conjugate Business (2017-2022) & (US$ Million)
Table 88. Biomed Recent Development
Table 89. Novartis Company Detail
Table 90. Novartis Business Overview
Table 91. Novartis Meningococcal Conjugate Product
Table 92. Novartis Revenue in Meningococcal Conjugate Business (2017-2022) & (US$ Million)
Table 93. Novartis Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Meningococcal Conjugate Market Share by Type: 2021 VS 2028
Figure 2. Menactra Features
Figure 3. Menveo Features
Figure 4. NeisVac-C Features
Figure 5. Nimenrix Features
Figure 6. Others Features
Figure 7. Global Meningococcal Conjugate Market Share by End User in 2021 & 2028
Figure 8. Children Case Studies
Figure 9. Preteens or Teens Case Studies
Figure 10. Adults Case Studies
Figure 11. Meningococcal Conjugate Report Years Considered
Figure 12. Global Meningococcal Conjugate Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Meningococcal Conjugate Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Meningococcal Conjugate Market Share by Region: 2021 VS 2028
Figure 15. Global Meningococcal Conjugate Market Share by Players in 2021
Figure 16. Global Top Meningococcal Conjugate Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Conjugate as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Meningococcal Conjugate Revenue in 2021
Figure 18. North America Meningococcal Conjugate Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. North America Meningococcal Conjugate Market Share by Country (2017-2028)
Figure 20. United States Meningococcal Conjugate Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Meningococcal Conjugate Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Meningococcal Conjugate Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Meningococcal Conjugate Market Share by Country (2017-2028)
Figure 24. Germany Meningococcal Conjugate Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Meningococcal Conjugate Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Meningococcal Conjugate Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Meningococcal Conjugate Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Meningococcal Conjugate Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Meningococcal Conjugate Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Meningococcal Conjugate Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Meningococcal Conjugate Market Share by Region (2017-2028)
Figure 32. China Meningococcal Conjugate Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Japan Meningococcal Conjugate Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. South Korea Meningococcal Conjugate Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Southeast Asia Meningococcal Conjugate Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. India Meningococcal Conjugate Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Australia Meningococcal Conjugate Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Meningococcal Conjugate Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Meningococcal Conjugate Market Share by Country (2017-2028)
Figure 40. Mexico Meningococcal Conjugate Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Brazil Meningococcal Conjugate Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Meningococcal Conjugate Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Meningococcal Conjugate Market Share by Country (2017-2028)
Figure 44. Turkey Meningococcal Conjugate Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Saudi Arabia Meningococcal Conjugate Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Sanofi Pasteur Revenue Growth Rate in Meningococcal Conjugate Business (2017-2022)
Figure 47. Pfizer Revenue Growth Rate in Meningococcal Conjugate Business (2017-2022)
Figure 48. Glaxo Smith Kline Revenue Growth Rate in Meningococcal Conjugate Business (2017-2022)
Figure 49. Hualan Biological Engineering Revenue Growth Rate in Meningococcal Conjugate Business (2017-2022)
Figure 50. JN International Medical Corporation Revenue Growth Rate in Meningococcal Conjugate Business (2017-2022)
Figure 51. Baxter International Revenue Growth Rate in Meningococcal Conjugate Business (2017-2022)
Figure 52. Merck Revenue Growth Rate in Meningococcal Conjugate Business (2017-2022)
Figure 53. Serum Institute of India Revenue Growth Rate in Meningococcal Conjugate Business (2017-2022)
Figure 54. Biomed Revenue Growth Rate in Meningococcal Conjugate Business (2017-2022)
Figure 55. Novartis Revenue Growth Rate in Meningococcal Conjugate Business (2017-2022)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Encephalitis Vaccination Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102

According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......

Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 123

Market Overview of Global Avian Influenza Vaccines market: According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years. Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period. The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......

Global Avian Influenza Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155

According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......

Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Encephalitis Vaccination market: According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......

Global Influenza Vaccine Market Research Report 2023

Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 96

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Sanofi - CSL - GSK - Viatris - AstraZeneca - Hualan Bio - Changchun Institute of Biological - Sinovac - BCHT - Jiangsu G......

Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 117

Market Overview of Global Japanese Encephalitis Vaccine market: According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......

Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Influenza Vaccine market: According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... ......

2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel

Published: 11-Dec-2023        Price: US 2500 Onwards        Pages: 107

This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Influenza Vaccine from......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs